Total Payments
$6,580
2024 Payments
$525.48
Companies
42
Transactions
472
Medicare Patients
707
Medicare Billing
$70,464
Payment Breakdown by Category
Food & Beverage$6,533 (99.3%)
Education$47.04 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,533 | 468 | 99.3% |
| Education | $47.04 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $951.94 | 69 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $616.15 | 41 | $0 (2020) |
| PFIZER INC. | $552.54 | 51 | $0 (2023) |
| Novo Nordisk Inc | $504.60 | 45 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $500.52 | 39 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $485.26 | 25 | $0 (2023) |
| Lilly USA, LLC | $410.10 | 32 | $0 (2023) |
| GlaxoSmithKline, LLC. | $302.73 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $284.58 | 18 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $242.04 | 17 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.48 | 28 | ABBVIE INC. ($223.70) |
| 2023 | $579.40 | 36 | AbbVie Inc. ($220.83) |
| 2022 | $729.10 | 48 | ABBVIE INC. ($280.00) |
| 2021 | $525.54 | 39 | AbbVie Inc. ($211.62) |
| 2020 | $535.58 | 36 | Janssen Pharmaceuticals, Inc ($126.57) |
| 2019 | $861.58 | 60 | AstraZeneca Pharmaceuticals LP ($140.09) |
| 2018 | $1,168 | 90 | SANOFI-AVENTIS U.S. LLC ($184.28) |
| 2017 | $1,655 | 135 | PFIZER INC. ($223.54) |
All Payment Transactions
472 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: VIROLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.24 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: VIROLOGY | ||||||
| 10/15/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: OUD | ||||||
| 09/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: VIROLOGY | ||||||
| 08/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: OUD | ||||||
| 08/14/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.85 | General |
| Category: Cardiovascular | ||||||
| 07/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: ANTIBIOTIC | ||||||
| 06/25/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: OUD | ||||||
| 06/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: VIROLOGY | ||||||
| 05/01/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.08 | General |
| Category: Cardiovascular | ||||||
| 04/30/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: OUD | ||||||
| 04/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: NEUROSCIENCE | ||||||
| 04/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Gastroenterology | ||||||
| 04/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: NEUROSCIENCE | ||||||
| 04/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: PSYCHIATRY | ||||||
| 02/28/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: OUD | ||||||
| 02/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: PSYCHIATRY | ||||||
| 02/21/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Opioid Use Disorder | ||||||
| 02/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 79 | 141 | $1,557 | $900.62 |
| 2022 | 3 | 358 | 911 | $74,133 | $45,547 |
| 2021 | 2 | 90 | 186 | $13,995 | $8,674 |
| 2020 | 5 | 180 | 508 | $35,118 | $15,342 |
Total Patients
707
Total Services
1,746
Medicare Billing
$70,464
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 71 | $1,207 | $675.92 | 56.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 39 | 70 | $350.00 | $224.70 | 64.2% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2022 | 251 | 718 | $71,800 | $44,200 | 61.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 58 | 114 | $1,938 | $1,092 | 56.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 49 | 79 | $395.00 | $254.63 | 64.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 51 | 131 | $13,100 | $8,140 | 62.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 39 | 55 | $895.31 | $534.05 | 59.6% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 64 | 279 | $17,786 | $8,030 | 45.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 41 | 78 | $7,766 | $3,538 | 45.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 20 | 78 | $8,236 | $3,068 | 37.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 43 | 60 | $971.40 | $581.27 | 59.8% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 12 | 13 | $358.28 | $124.57 | 34.8% |
About Dr. Christopher Bailey, DO
Dr. Christopher Bailey, DO is a Addiction Medicine healthcare provider based in Prestonsburg, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275602070.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Bailey, DO has received a total of $6,580 in payments from pharmaceutical and medical device companies, with $525.48 received in 2024. These payments were reported across 472 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,533).
As a Medicare-enrolled provider, Bailey has provided services to 707 Medicare beneficiaries, totaling 1,746 services with total Medicare billing of $70,464. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Addiction Medicine
- Other Specialties Family Medicine
- Location Prestonsburg, KY
- Active Since 11/07/2006
- Last Updated 07/14/2017
- Taxonomy Code 207QA0401X
- Entity Type Individual
- NPI Number 1275602070
Products in Payments
- FARXIGA (Drug) $411.40
- UBRELVY (Drug) $328.27
- JARDIANCE (Drug) $302.86
- XARELTO (Drug) $289.36
- ENTRESTO (Drug) $261.91
- TOUJEO (Drug) $244.41
- QULIPTA (Drug) $244.23
- SUBLOCADE (Drug) $215.17
- Ozempic (Drug) $210.08
- CHANTIX (Drug) $205.18
- INVOKANA (Drug) $205.14
- Victoza (Drug) $170.49
- MAVYRET (Drug) $164.28
- VRAYLAR (Drug) $162.43
- SOLIQUA (Drug) $161.18
- TRULICITY (Drug) $147.23
- ELIQUIS (Drug) $141.63
- LYRICA (Drug) $136.56
- LINZESS (Drug) $109.18
- Vascepa (Drug) $104.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.